Wells Fargo & Company Issues Pessimistic Forecast for Hamilton Lane (NASDAQ:HLNE) Stock Price

Hamilton Lane (NASDAQ:HLNEFree Report) had its price objective cut by Wells Fargo & Company from $169.00 to $152.00 in a research note issued to investors on Thursday,Benzinga reports. They currently have an equal weight rating on the stock.

A number of other research firms have also recently commented on HLNE. The Goldman Sachs Group cut Hamilton Lane from a “neutral” rating to a “sell” rating and set a $139.00 price target for the company. in a research note on Monday, January 6th. Keefe, Bruyette & Woods increased their price objective on shares of Hamilton Lane from $158.00 to $168.00 and gave the company a “market perform” rating in a research report on Wednesday, February 5th. Finally, Oppenheimer upgraded shares of Hamilton Lane from a “market perform” rating to an “outperform” rating and set a $186.00 target price for the company in a research note on Tuesday, January 21st. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat.com, Hamilton Lane has an average rating of “Hold” and a consensus price target of $170.71.

Get Our Latest Stock Report on HLNE

Hamilton Lane Stock Down 0.9 %

Shares of Hamilton Lane stock opened at $149.20 on Thursday. The company has a quick ratio of 4.19, a current ratio of 4.19 and a debt-to-equity ratio of 0.34. The company has a market cap of $8.27 billion, a P/E ratio of 27.53 and a beta of 1.28. The firm’s 50 day moving average price is $152.88 and its 200-day moving average price is $164.71. Hamilton Lane has a 52-week low of $107.22 and a 52-week high of $203.72.

Hamilton Lane (NASDAQ:HLNEGet Free Report) last released its quarterly earnings results on Tuesday, February 4th. The company reported $1.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.13 by $0.12. Hamilton Lane had a net margin of 31.12% and a return on equity of 36.69%. The business had revenue of $168.26 million for the quarter, compared to analyst estimates of $158.86 million. During the same period in the previous year, the company earned $0.71 earnings per share. The business’s revenue for the quarter was up 34.3% on a year-over-year basis. On average, sell-side analysts predict that Hamilton Lane will post 4.97 EPS for the current fiscal year.

Hamilton Lane Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 4th. Investors of record on Friday, March 14th will be given a $0.49 dividend. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.96 dividend on an annualized basis and a yield of 1.31%. Hamilton Lane’s dividend payout ratio is currently 36.16%.

Hedge Funds Weigh In On Hamilton Lane

A number of institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. boosted its holdings in shares of Hamilton Lane by 28.4% in the 4th quarter. Vanguard Group Inc. now owns 3,901,933 shares of the company’s stock valued at $577,681,000 after acquiring an additional 863,326 shares during the last quarter. Invesco Ltd. lifted its position in Hamilton Lane by 25.3% during the fourth quarter. Invesco Ltd. now owns 1,923,253 shares of the company’s stock valued at $284,738,000 after purchasing an additional 388,019 shares during the period. Wellington Management Group LLP boosted its holdings in Hamilton Lane by 31.1% in the third quarter. Wellington Management Group LLP now owns 1,743,033 shares of the company’s stock valued at $293,509,000 after purchasing an additional 413,015 shares during the last quarter. State Street Corp raised its stake in shares of Hamilton Lane by 53.7% during the 3rd quarter. State Street Corp now owns 1,401,909 shares of the company’s stock valued at $236,516,000 after buying an additional 489,557 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD raised its stake in shares of Hamilton Lane by 229.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 1,292,266 shares of the company’s stock valued at $191,321,000 after buying an additional 900,283 shares during the last quarter. 97.40% of the stock is owned by hedge funds and other institutional investors.

About Hamilton Lane

(Get Free Report)

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.

Featured Stories

Analyst Recommendations for Hamilton Lane (NASDAQ:HLNE)

Receive News & Ratings for Hamilton Lane Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Lane and related companies with MarketBeat.com's FREE daily email newsletter.